Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report

Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report

Abstract Background Complement component 3 (C3) glomerulopathy, which includes dense deposit disease (DDD) and C3 glomerulonephritis, is caused by dysregulation of the alternative complement pathway. In most cases, C3 glomerulopathy manifests pathologically with membranoproliferative glomerulonephri...

Full description

Bibliographic Details
Main Authors: Shuma Hirashio, Ayaka Satoh, Takahiro Arima, Kouichi Mandai, Tadasuke Awaya, Kumi Oshima, Shigeo Hara, Takao Masaki
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Nephrology
Subjects:
C3 glomerulopathy
Complement
Dense deposit disease
Monoclonal gammopathy of renal significance
Monoclonal gammopathy of undetermined significance
Online Access:http://link.springer.com/article/10.1186/s12882-018-0905-6

Internet

http://link.springer.com/article/10.1186/s12882-018-0905-6

Similar Items